EX-32.1 4 exhibit321-certificationpu.htm EX-32.1
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 5, 2022 |  | Date: August 5, 2022
By: | /s/ Paul J. Diaz |  | By: | /s/ R. Bryan Riggsbee
Paul J. Diaz |  | R. Bryan Riggsbee
President and Chief Executive Officer |  | Chief Financial Officer
Principal Executive Officer |  | Principal Financial and Accounting Officer